BeOne Medicines
ONC
#818
Rank
C$42.87 B
Marketcap
C$413.22
Share price
2.02%
Change (1 day)
24.05%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: C$42.87 Billion

As of July 2026 BeOne Medicines has a market cap of C$42.87 Billion. This makes BeOne Medicines the world's 818th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026C$42.87 B-9.44%
2025C$47.34 B61.08%
2024C$29.38 B12.4%
2023C$26.14 B-24.24%
2022C$34.51 B-2.56%
2021C$35.41 B17.36%
2020C$30.17 B126.15%
2019C$13.34 B17.22%
2018C$11.38 B103.46%
2017C$5.59 B245.63%
2016C$1.61 B

End of Day market cap according to different sources

On Jul 1st, 2026 the market cap of BeOne Medicines was reported to be:

C$45.93 Billion
by Nasdaq info icon info icon
C$42.87 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
C$1.64 B-96.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C$29.71 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA